Wacker Chemie turns to biopharma during period of uncertainty
Wacker Biotech looks to corner the microbial expression system niche, as Wacker Chemie’s traditional areas of focus face difficult market conditions.
Archives for July 12, 2019
US failure to adopt biosimilars costs $7.2bn every year
With US spending on biologics reaching $125.5bn in 2018, a new report looks at the level of savings that could potentially be made and contrasts the US with the European market.